* Flexion Therapeutics enrolls first patient in phase 2
trial of Zilretta among Type 2 diabetes patients with knee
osteoarthritis
Source text for Eikon:
Further company coverage:
(Bengaluru…
The post BRIEF-Flexion Therapeutics enrolls first patient in Phase 2 trial of Zilretta appeared first on NASDAQ.